BLIN vs GSK · rev $15.4M vs P/E 13, $103.31B cap
Bridgeline Digital Inc (BLIN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Bridgeline Digital Inc (BLIN) is a software - infrastructure company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BLIN revenue for 2024-09-30 was $15.4M. Net income was -$2.0M. Revenue was down 3.3% from 2023-09-30 to 2024-09-30. BLIN currently screens at market cap $13.4M.
GSK does not have a complete income-statement cache yet.
BLIN currently screens at market cap $13.4M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BLIN and GSK stock pages for the full models.
Not investment advice.